Women who start hormone therapy, such as taking the estrogen pill Premarin, may also be benefiting their brains by reducing the risk of Alzheimer's Disease.
A new study widely reported today showed women who started hormone therapy within five years of hitting menopause were 30 percent less likely to develop Alzheimer's. Those who started on Premarin after five years did not see a similar decline in risk.
The estrogen replacement drug is often prescribed to deal with symptoms of menopause, such as hot flashes and night sweats.
“As a result of our study, I don’t think women should change their behaviors just yet," Peter Zandi, an associate professor at the Johns Hopkins Bloomberg School of Public Health told BusinessWeek. "They shouldn’t think that they’re going to take hormone therapies to protect against Alzheimer’s disease.”
Researchers followed 1,768 women ages 65 and older for 11 years. Of ther 1,105 taking hormone therapy, 87 developed Alzheimer’s disease, while 89 of 663 who didn’t take the treatments got the disease.
Read more: Hormone Therapy May Cut Alzheimer's Risk